You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015.
Over the next month, the leading American cannabis companies will be reporting their 4th quarter financial results, beginning with Green Thumb Industries on March 1st and Curaleaf on March 3rd.
As we have discussed previously, the timing of New Jersey commencing adult-use sales is a major factor in terms of potential revenue in 2022 for many of these companies, so we could see guidance with asterisks from some operators.
With that said, we believe that investors are well aware of the recent sluggishness in cannabis sales and the delay in New Jersey.
After 13 extremely successful editions in Toronto, Chicago, Detroit, New York and Miami, the Benzinga Cannabis Capital Conference is going bigger than ever.
To get real-time updates download our free mobile app for Android or Apple devices, like our Facebook page, or follow Alan on Twitter.
Get ahead of the crowd! If you are a cannabis investor and find value in our Sunday newsletters, subscribe to 420 Investor, Alan’s comprehensive stock due diligence platform since 2013.
Use the suite of professionally managed NCV Cannabis Stock Indices to monitor the performance of publicly-traded cannabis companies within the day or over longer time-frames.